Clinical trials recruiting for Neoadjuvant Therapy

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer
  NCT05906407 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 12 locations
• Digital Mind-Body Therapy for Neoadjuvant Breast Cancer
  NCT07541664 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer
  NCT06642428 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
  NCT06613165 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• FAP-targeted PET/NIR in Lung Malignant Tumors
  NCT07498933 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC
  NCT07492342 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
  NCT07359040 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
  NCT04486495 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 35 locations
• Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer
  NCT04743102 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
  NCT06241807 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer
  NCT07458529 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)
  NCT06832904 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
  NCT05406999 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• Neoadjuvant SNF Precision Therapy Phase III
  NCT06913777 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant Chemotherapy
  NCT06704945 · Phase: Phase 3 · Ages: 19 Years and older · Sex: Female · 1 location
• Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer
  NCT07695259 · Phase: Phase 4 · Ages: 60 Years and older · Sex: Female · 1 location
• Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）
  NCT07388771 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
  NCT06719206 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC
  NCT07135856 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer
  NCT06743581 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)
  NCT07291921 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
  NCT06758830 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer
  NCT06904677 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Neoadjuvant Therapy often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Neoadjuvant Therapy trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.